APA (7th ed.) Citation

Saxena, T., Sharvani, A., Stavika, A., & Rohini, M. (2026). Regulatory considerations for messenger RNA vaccines: A comprehensive review on World Health Organization guidelines on development, production, and clinical evaluation. Perspectives in Clinical Research, 17(3), 134. https://doi.org/10.4103/picr.picr_199_25

Chicago Style (17th ed.) Citation

Saxena, Trapti, Almula Sharvani, Aluvala Stavika, and Mirdhodie Rohini. "Regulatory Considerations for Messenger RNA Vaccines: A Comprehensive Review on World Health Organization Guidelines on Development, Production, and Clinical Evaluation." Perspectives in Clinical Research 17, no. 3 (2026): 134. https://doi.org/10.4103/picr.picr_199_25.

MLA (9th ed.) Citation

Saxena, Trapti, et al. "Regulatory Considerations for Messenger RNA Vaccines: A Comprehensive Review on World Health Organization Guidelines on Development, Production, and Clinical Evaluation." Perspectives in Clinical Research, vol. 17, no. 3, 2026, p. 134, https://doi.org/10.4103/picr.picr_199_25.